IOVANCE BIOTHERAPEUTICS INC shareholders Q3 2023

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 228 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.

IOVANCE BIOTHERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
FOX RUN MANAGEMENT, L.L.C. 16,079$73,1590.02%
Point72 Asset Management, L.P. 1,412,550$6,427,1030.02%
MILLENNIUM MANAGEMENT LLC 7,820,074$35,581,3370.02%
SANDERS MORRIS HARRIS LLC 16,200$71,6040.02%
XTX Topco Ltd 18,863$85,8270.02%
Hudson Bay Capital Management LP 860,400$3,914,8200.02%
SG Americas Securities, LLC 276,393$1,2580.01%
CREDIT SUISSE AG/ 2,843,469$12,937,7840.01%
Capula Management Ltd 140,060$637,2730.01%
BALYASNY ASSET MANAGEMENT L.P. 1,430,000$6,506,5000.01%
Dynamic Technology Lab Private Ltd 26,791$1220.01%
Sandia Investment Management LP 10,000$45,5000.01%
Keystone Financial Group 15,000$68,2500.01%
GREAT LAKES ADVISORS, LLC 276,534$1,258,2300.01%
RMB Capital Management, LLC 69,817$317,6670.01%
Legato Capital Management LLC 17,445$79,3750.01%
Renaissance Technologies 1,226,400$5,5800.01%
GROUP ONE TRADING, L.P. 625,701$2,846,9400.01%
PANAGORA ASSET MANAGEMENT INC 333,974$1,519,5820.01%
J. Goldman & Co LP 54,000$245,7000.01%
External links

This page lists IOVANCE BIOTHERAPEUTICS INC's shareholders in Q3 2023. To view IOVANCE BIOTHERAPEUTICS INC's shareholder history, click here.